LYCOS RETRIEVER 
Cellegy Pharmaceuticals: Earlier Savvy
built 608 days ago
Cellegy Pharmaceuticals is a specialty biopharmaceutical company that develops and commercializes prescription drugs for the treatment of women's health care conditions, including sexual dysfunction, HIV prevention and gastrointestinal disorders. Savvy(R) (C31G vaginal gel), a novel microbicide gel product for contraception and the reduction in transmission of HIV in women, is currently undergoing Phase 3 clinical studies in the United States and Africa.
Source:
Cellegy Pharmaceuticals is a specialty biopharmaceutical company that specializes in women's health. Savvy(R) (C31G vaginal gel), a microbicide gel product for contraception, is currently undergoing Phase 3 clinical studies in the United States for contraception.
Source:
HUNTINGDON VALLEY, Penn., June 20 /PRNewswire-FirstCall/ -- Cellegy Pharmaceuticals, Inc. announced today that it has appointed Agis Commercial Agencies Ltd. as its exclusive distributor for Rectogesic(R) nitroglycerin ointment in Israel. Agis will file for regulatory approval utilizing the European Common Technical Document that provided the basis for approval of Rectogesic by 20 European countries earlier this year.
Source:
FHI, Cellegy, and USAID are continuing this important research in Nigeria where a second Savvy study is under way, in the hopes of finding an answer to the question of product effectiveness for HIV prevention. Consideration will be given to expanding the ongoing Nigeria study, if necessary after an interim analysis is completed, and/or beginning a new trial in locations with higher HIV incidence.
Source:
Biosyn's lead product, a microbicide gel called Savvy, became Cellegy's most advanced and promising product. The vaginal lubricant is now in late-stage clinical trials for prevention of sexual transmission of HIV and as a contraceptive. Cellegy hopes to file a new drug application for Savvy in "18 months to two years," Williams said.
Source:
-- Cellegy Pharmaceuticals, Inc. has been notified that there were technical difficulties experienced by individuals trying to access the webcast link on http://www.cellegy.com/ for the conference call that took place earlier today. The issue has since been corrected.
Source:
MORE ABOUT
Earlier Savvy